01 BNF Preface Flashcards
What is multimorbidity?
The presence of two or more long-term health conditions in a patient.
What is multimorbidity associated with?
- Reduced quality of life
- Higher mortality
- Higher rates of adverse drug reactions
- Greater use of health service
- Higher treatment burden (due to polypharmacy or multiple appointments)
What is deprescribing?
Deprescribing is the process of discontinuing or reducing the dose of medicines with the aim of managing polypharmacy and improving outcomes. Should be supervised by a healthcare professional.
What does deprescribing require?
Deprescribing requires careful counselling and shared decision-making with patients and is considered part of routine clinical care.
List the factors contributing to poor compliance with prescribed medicines: (9)
- prescription not collected or dispensed
- purpose of medicine not clear
- perceived lack of efficacy
- real or perceived side effects
- patient’s perception of risk and severity of S/E differs from that of prescriber
- unclear administration directions
- physical difficulty in taking meds
- unattractive formulation (taste)
- complicated regimen
What is concordance?
The prescriber and patient should agree on the health outcomes that the patient desires and on the strategy for achieving them.
List ways of improving adherence: (4)
- explaining rationale and S/E of treatment
- reinforcement of dr’s instructions by pharmacist
- advising patient of possibility of alternative treatments
- simplifying drug regimen e.g combination products
What are biological medicines?
Biological medicines are medicines made by/derived from a biological source using biotechnology processes e.g recombinant DNA technology.
Why is variation present in biological medicines?
The size and complexity of biological medicines as well as their method of production may result in a degree of of natural variability in molecules of the same active, particularly in different batches of the medicine. This variation is maintained within strict acceptable limits.
Give 2 examples of biological medicines and how they are prescribed:
(1) Insulin
(2) Monoclonal antibodies
Biological medicines must be prescribed by brand names.
What is a biosimilar medicine?
A biosimilar medicine is a biological medicine that is highly similar and clinically equivalent (in quality, safety & efficacy) to an existing biological medicine that has been authorised in the EU (originator/reference medicine).
What is the difference between biological and its biosimilar medicine and when can it be authorised?
The active substance of a biosimilar is similar, but not identical, to its originator.
Once a patent for a biological medicine has expired, a biosimilar medicine may be authorised by the EMA.
What is the difference between a biosimilar and a generic medicine?
Biosimilars and generics should not be considered the same thing.
Generic medicines contain a simpler molecular structure that is IDENTICAL to the originator medicine.
Are biosimilars considered to be therapeutically equivalent to originators?
Yes, within their authorised indications. Biosimilars are usually licensed to all indications of originators, depending on evidence submitted to EMA.
What is the safety monitoring associated with biosimilar medicines?
Biosimilar medications have black triangle status at the time of initial authorisation. Report ADR using yellow card scheme. For all biological medicines, state batch number and brand name on ADR report.
List a few drugs available as biosimilar medicines: (14)
- Adalimumab
- Bevacizumab
- Enoxaparin sodium
- Epoeitin Alfa
- Epoeitin zeta
- Etanercept
- Filgrastim
- Follitropin alfa
- Infliximab
- Insulin glargine
- Insulin lispro
- Rituximab
- Somatropin
- Teriparatide
What is an unlicensed medicine and when is it necessary?
An unlicensed medicine is a medicine used outside the terms of their UK license or which have no license in the UK.
Unlicensed use of a medicine may be necessary when clinical need cannot be met by existing licensed medicines.
What is ‘off-label’ use of a medicine?
When a medicine is used or administered via a route outside of the licensed indication of the product.
(Excipients)
When can a branded oral liquid preparation be described as ‘sugar-free’?
Liquid products that do not contain: • fructose • glucose • sucrose Preparations containing these can also be described as sugar-free as they do not cause dental caries (non-cariogenic): • hydrogenated glucose syrup • mannitol • maltitol • sorbitol • xylitol
What excipients are marked in the BNF? (6)
- Aspartame
- Gluten
- Sulfites
- Tartrazine
- Arachis (peanut oil)
- Sesame oil
Which excipients for injections are indicated in the BNF and why?
Presence of benzyl alcohol and polyoxyl castor oil in injections is indicated.
Benzyl alcohol has been associated with a fatal toxic syndrome in preterm neonates.
Polyoxyl castor oils (used as vehicles in IV injections) have been associated with severe anaphylactoid reactions.
Which excipient in oral & parenteral injection is indicated in the BNF and why?
Propylene glycol can cause adverse effects if elimination is impaired.
E.g. in renal failure, in neonates and young children, in slow metabolisers of the substance.
Propylene glycol may interact with disulfiram and metronidazole.
Is lactose content in medicines a problem for most lactose-intolerant patients?
The lactose content in most medicines is too small to cause problems in most lactose-intolerant patients.
But in severe lactose intolerance: lactose content should be determined before prescribing.
Amount of lactose varies according to manufacturer, product, formulation and strength.
(Extemporaneous preparation)
When should a product be dispensed extemporaneously?
Only when no product with a marketing authorisation is available.